GO:0070676 intralumenal vesicle formation: Endosomal Sorting Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070676 intralumenal vesicle formation is the biological process in which the endosomal membrane invaginates to form vesicles within the endosome lumen, defining the multivesicular body (MVB).
• The process is driven by the ESCRT machinery, including ESCRT-0, -I, -II, -III, and associated factors such as Bro1 and Vps4, which mediate cargo sorting and membrane scission.
• Intralumenal vesicle formation is essential for sorting ubiquitinated membrane proteins to the lysosome for degradation and for the biogenesis of exosomes.
• Disruption of intralumenal vesicle formation is linked to cancer, neurodegeneration, and liver fibrosis through altered exosome-mediated signaling and defective autophagy.
• Key regulatory proteins include Bro1, which stimulates Vps4 ATPase activity, and Lgd, which controls ESCRT-III accumulation at endosomes.
• Research on this process uses CRISPR knockout, knock-in, and overexpression models combined with imaging, proteomics, and RNA sequencing to dissect molecular mechanisms.
Description
Intralumenal vesicle formation (GO:0070676) is a fundamental cellular process in which the limiting membrane of an endosome invaginates inward to generate small vesicles within the endosomal lumen. This process is the defining event in the biogenesis of multivesicular bodies (MVBs), which are late endosomal compartments that sort cargo for degradation or release as exosomes. The formation of intralumenal vesicles (ILVs) is highly conserved across eukaryotes and is mediated by the endosomal sorting complex required for transport (ESCRT) machinery, a set of protein complexes that recognize ubiquitinated cargo, deform the membrane, and catalyze scission. Beyond its role in protein degradation, intralumenal vesicle formation is critical for extracellular vesicle biogenesis, intercellular communication, and cellular quality control. For researchers, understanding intralumenal vesicle formation is essential because defects in this pathway underlie a wide range of human diseases, including cancer, neurodegenerative disorders, and metabolic conditions. The process is also a target for therapeutic intervention, as modulating ILV formation can alter exosome cargo and signaling. Recent studies have expanded the known players in this process, including Bro1, which stimulates the Vps4 ATPase to promote ILV formation, and Lgd, which regulates ESCRT-III dynamics. Additionally, emerging evidence suggests that similar membrane remodeling mechanisms operate in peroxisomes, highlighting the broader relevance of intralumenal vesicle formation principles. This article provides a comprehensive overview of the molecular mechanisms, key genes, regulatory networks, and experimental models used to study intralumenal vesicle formation. By integrating authoritative QuickGO annotations with peer-reviewed literature, we aim to equip researchers with a clear framework for investigating this process and its implications in health and disease.
intralumenal vesicle formation At A Glance
| GO ID | GO:0070676 |
|---|---|
| GO term | intralumenal vesicle formation |
| Ontology | biological_process |
| Synonym | endosome membrane budding |
| Major function | Formation of vesicles within the endosomal lumen, essential for multivesicular body biogenesis and cargo sorting |
| Cellular location | Endosomal membrane, multivesicular body |
| Key molecular players | ESCRT-0, ESCRT-I, ESCRT-II, ESCRT-III, Bro1, Vps4, Lgd |
| Associated processes | Protein degradation, exosome biogenesis, autophagy, membrane remodeling |
| Disease relevance | Cancer, neurodegeneration, liver fibrosis, metabolic disorders |
What Is GO:0070676?
Intralumenal vesicle formation is the process by which the endosomal membrane invaginates and buds inward, resulting in the formation of a vesicle within the lumen of the endosome. This definition is based on the Gene Ontology term GO:0070676, which captures the topological and functional essence of this membrane remodeling event.
Why Is intralumenal vesicle formation Important in Cell Biology?
Intralumenal vesicle formation is a central mechanism for cellular homeostasis, as it controls the sorting of membrane proteins, lipids, and cytosolic cargo into intralumenal vesicles for degradation or secretion. This process is essential for the downregulation of signaling receptors, the clearance of damaged proteins, and the production of exosomes that mediate intercellular communication. Dysregulation of intralumenal vesicle formation contributes to cancer progression, neurodegenerative diseases, and fibrotic disorders, making it a critical area of biomedical research.
• Controls degradation of ubiquitinated membrane proteins via the multivesicular body pathway.
• Essential for exosome biogenesis and extracellular vesicle-mediated intercellular communication.
• Regulates cell surface receptor downregulation and signaling attenuation.
• Implicated in cancer through altered exosome cargo and tumor microenvironment remodeling.
• Linked to neurodegeneration via defective clearance of aggregation-prone proteins.
• Plays a role in liver fibrosis by modulating exosome-mediated hepatic stellate cell activation.
• Conserved mechanism from yeast to plants to humans, enabling comparative studies.
• Provides a model for understanding membrane remodeling in peroxisomes and other organelles.
• Target for therapeutic modulation of exosome production in disease.
• Requires precise regulation by ESCRT components and accessory proteins like Bro1 and Lgd.
What Happens During intralumenal vesicle formation?
Cargo Recognition and ESCRT-0 Recruitment
In simple terms: The cell tags unwanted membrane proteins with ubiquitin, and ESCRT-0 recognizes these tags on the endosome surface.
The first step in intralumenal vesicle formation involves the recognition of ubiquitinated cargo proteins on the endosomal membrane. ESCRT-0, a heterodimeric complex, binds to both ubiquitin and phosphatidylinositol 3-phosphate (PI3P) on the endosomal membrane, clustering cargo and initiating the recruitment of downstream ESCRT components. This step ensures that specific proteins destined for degradation or exosomal release are concentrated at the site of vesicle formation.
Membrane Invagination and ESCRT-I/II Function
In simple terms: ESCRT-I and ESCRT-II help bend the membrane inward, starting to form a bud.
Following cargo recognition, ESCRT-I and ESCRT-II are recruited to the endosomal membrane. These complexes interact with ESCRT-0 and with each other to stabilize the budding site and induce membrane curvature. ESCRT-I and ESCRT-II also participate in cargo sorting by binding ubiquitinated proteins and facilitating their concentration into the nascent intralumenal vesicle. The coordinated action of these complexes is essential for the formation of a stable invagination.
ESCRT-III Polymerization and Membrane Scission
In simple terms: ESCRT-III forms a spiral that pinches off the vesicle inside the endosome.
ESCRT-III is the core machinery that catalyzes membrane scission. Upon recruitment, ESCRT-III subunits polymerize into filaments that constrict the neck of the invaginating vesicle. The ATPase Vps4 is recruited by Bro1 and other factors to disassemble ESCRT-III and provide energy for scission. Lgd (also known as Lethal giant discs) regulates the accumulation of ESCRT-III at endosomes, ensuring proper timing and location of scission. This step results in the release of the intralumenal vesicle into the endosomal lumen.
Vesicle Release and MVB Maturation
In simple terms: The vesicle is now inside the endosome, and the endosome becomes a multivesicular body.
After scission, the intralumenal vesicle is fully enclosed within the endosomal lumen. The endosome, now containing multiple ILVs, is termed a multivesicular body (MVB). MVBs can either fuse with the lysosome to degrade their contents or fuse with the plasma membrane to release ILVs as exosomes. The sorting of cargo into ILVs determines the fate of the proteins and lipids, influencing cellular signaling and communication.
Conservation and Variations in Other Organelles
In simple terms: Similar vesicle-making processes occur in other parts of the cell, like peroxisomes.
While intralumenal vesicle formation is best characterized in endosomes, recent studies have identified analogous processes in peroxisomes, where PEX11 mediates the formation of intralumenal vesicles. In plants, ESCRT-mediated sorting and ILV concatenation have been observed, highlighting evolutionary conservation. These findings suggest that the fundamental mechanisms of membrane invagination and scission are shared across organelles and organisms.
Key Genes Involved in GO:0070676 intralumenal vesicle formation
The following genes and proteins are central to intralumenal vesicle formation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VPS4 | AAA-ATPase that disassembles ESCRT-III and drives membrane scission | Essential for ILV formation; knockout leads to MVB defects |
| BRO1 | Stimulates Vps4 ATPase activity and ESCRT-III disassembly | Regulates ILV formation; mutations affect MVB biogenesis |
| LGD | Regulates ESCRT-III accumulation at endosomes | Controls ILV formation; loss causes overaccumulation of ESCRT-III |
| ESCRT-0 | Binds ubiquitinated cargo and PI3P, initiates ILV formation | Cargo sorting; knockdown impairs receptor degradation |
| ESCRT-I | Membrane curvature and cargo sorting | Required for ILV formation; mutations affect exosome cargo |
| ESCRT-II | Stabilizes budding site and interacts with ESCRT-III | Facilitates ILV formation; depletion blocks MVB biogenesis |
| ESCRT-III | Polymerizes to constrict membrane neck and catalyze scission | Core scission machinery; mutations cause neurodegeneration |
| PEX11 | Mediates intralumenal vesicle formation in peroxisomes | Expands ILV concept to peroxisomes |
| SQSTM1 | Autophagy receptor involved in ILV-related degradation | Links ILV formation to autophagy and liver fibrosis |
| TRIB3 | Interacts with SQSTM1 to regulate autophagy and exosome release | Modulates ILV-dependent exosome secretion |
| VPS25 | ESCRT-II subunit | Required for ILV formation and receptor downregulation |
| VPS36 | ESCRT-II subunit | Cargo sorting and ILV biogenesis |
| SNF7 | ESCRT-III subunit | Membrane scission; knockdown inhibits ILV formation |
| VPS20 | ESCRT-III subunit | Initiates ESCRT-III polymerization |
| CHMP4B | ESCRT-III subunit | Membrane remodeling; mutations linked to cataracts |
| ALIX | Accessory protein that recruits ESCRT-III | Facilitates ILV formation and exosome biogenesis |
| TSG101 | ESCRT-I subunit | Cargo sorting and ILV formation; knockdown blocks MVB |
| HRS | ESCRT-0 subunit | Binds ubiquitinated cargo; essential for ILV formation |
How Is intralumenal vesicle formation Regulated?
Intralumenal vesicle formation is tightly regulated at multiple levels. The ESCRT machinery is recruited to endosomes in a sequential manner, with ESCRT-0 binding to PI3P and ubiquitinated cargo, followed by ESCRT-I, -II, and -III. Bro1 stimulates the ATPase activity of Vps4, which is required for ESCRT-III disassembly and recycling, thereby controlling the rate of ILV formation. Lgd regulates the accumulation of ESCRT-III at endosomes, preventing premature or excessive scission. Additionally, post-translational modifications such as ubiquitination and phosphorylation modulate the activity and interactions of ESCRT components. The process is also influenced by lipid composition, particularly the presence of PI3P and other phosphoinositides. In the context of autophagy, SQSTM1 and TRIB3 interact to regulate exosome-mediated signaling, linking ILV formation to cellular stress responses. Furthermore, microautophagy, a related process, shares mechanistic features with ILV formation and is subject to similar regulatory inputs.
intralumenal vesicle formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRIB3 | Liver fibrosis, exosome-mediated HSC activation | Knockout or point mutation in hepatic stellate cells |
| SQSTM1 | Autophagy dysfunction, liver fibrosis | Knockout in hepatocytes or HSCs |
| CHMP4B | Neurodegeneration, cataracts | Knock-in of disease-associated mutations in neurons |
| VPS4 | MVB biogenesis defects, cancer | Knockout or overexpression in cancer cell lines |
| PEX11 | Peroxisomal disorders | Knockout in peroxisome-deficient models |
Cancer and Exosome-Mediated Signaling
Intralumenal vesicle formation is critical for the production of exosomes, which are extracellular vesicles that mediate intercellular communication in the tumor microenvironment. Cancer cells often exhibit altered exosome cargo, and disruption of ILV formation can affect tumor progression, metastasis, and immune evasion. For example, the TRIB3-SQSTM1 interaction regulates exosome-mediated activation of hepatic stellate cells, contributing to liver fibrosis and potentially hepatocellular carcinoma. Targeting ILV formation may therefore offer therapeutic opportunities in cancer.
Neurodegeneration and Defective Protein Clearance
Defects in intralumenal vesicle formation impair the degradation of aggregation-prone proteins, leading to their accumulation and neurotoxicity. Mutations in ESCRT-III subunits such as CHMP4B have been linked to neurodegenerative disorders, and impaired MVB sorting is observed in Alzheimer's and Parkinson's diseases. Microautophagy, which shares molecular machinery with ILV formation, also plays a role in neuronal protein quality control. Understanding how ILV formation is dysregulated in neurons could inform new therapeutic strategies.
Liver Fibrosis and Autophagy-Exosome Crosstalk
Disruption of the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated hepatic stellate cell activation. This highlights the interplay between intralumenal vesicle formation, autophagy, and fibrotic disease. Modulating ILV formation could therefore be a strategy to treat liver fibrosis and other fibrotic conditions.
Peroxisomal Disorders and Emerging Roles
The discovery that PEX11 mediates intralumenal vesicle formation in peroxisomes suggests that defects in this process may contribute to peroxisomal disorders. While the clinical implications are still emerging, this finding expands the relevance of ILV formation beyond endosomes and highlights the need for further research.
From intralumenal vesicle formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of VPS4 block intralumenal vesicle formation? | CRISPR knockout of VPS4 in HeLa or HEK293 cells |
| How does Bro1 stimulate Vps4 ATPase activity? | Point mutation of Bro1 catalytic residues followed by in vitro ATPase assay |
| What is the effect of Lgd overexpression on ESCRT-III accumulation? | Overexpression of Lgd in Drosophila or mammalian cells |
| Can a disease-associated CHMP4B mutation impair ILV formation? | Knock-in of mutant CHMP4B in neuronal cell lines |
| How does TRIB3-SQSTM1 interaction affect exosome release? | Knockout of TRIB3 or SQSTM1 in hepatic stellate cells |
| Does PEX11 mediate ILV formation in peroxisomes? | Knockout of PEX11 in peroxisome reporter cells |
How to Study the intralumenal vesicle formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transmission electron microscopy (TEM) | Number, size, and morphology of intralumenal vesicles | Quantifying ILV formation in knockout or mutant cells |
| Immunoelectron microscopy | Localization of specific proteins on ILVs | Identifying cargo sorted into ILVs |
| Live-cell fluorescence microscopy | Dynamics of ESCRT recruitment and scission | Real-time imaging of ILV formation |
| Proteomics (mass spectrometry) | Protein composition of ILVs and exosomes | Discovering novel ILV cargo and regulators |
| RNA sequencing | Transcriptional changes upon ILV perturbation | Identifying disease-relevant gene expression signatures |
| Western blotting | Protein levels of ESCRT components and cargo | Validating knockout or knockdown efficiency |
| Co-immunoprecipitation | Protein-protein interactions among ESCRT subunits | Mapping the ESCRT interaction network |
| In vitro membrane scission assays | Ability of ESCRT-III to catalyze membrane scission | Reconstituting ILV formation with purified components |
Imaging Intralumenal Vesicles by Electron Microscopy
Transmission electron microscopy (TEM) is the gold standard for visualizing intralumenal vesicles within multivesicular bodies. TEM allows researchers to quantify the number and size of ILVs and assess the integrity of the endosomal membrane. Immunoelectron microscopy can further localize specific cargo or ESCRT components to ILVs.
Fluorescence Microscopy and Live-Cell Imaging
Fluorescently tagged ESCRT components and cargo proteins can be used to track the dynamics of ILV formation in live cells. Total internal reflection fluorescence (TIRF) microscopy and spinning-disk confocal microscopy enable real-time visualization of ESCRT recruitment and membrane scission events. These methods are particularly useful for studying the kinetics of ILV formation and the role of regulatory proteins like Lgd.
Proteomics and Mass Spectrometry
Proteomic approaches can identify the protein composition of intralumenal vesicles and the post-translational modifications that regulate ESCRT function. Mass spectrometry-based proteomics of isolated MVBs or exosomes reveals cargo sorted into ILVs and can uncover novel regulators. Quantitative proteomics comparing wild-type and mutant cells can pinpoint changes in ILV cargo.
RNA Sequencing and Transcriptomics
RNA sequencing can assess transcriptional changes resulting from perturbations in ILV formation. For example, knockout of TRIB3 or SQSTM1 alters gene expression programs related to autophagy and fibrosis. Transcriptomic profiling of cells with ESCRT mutations can reveal compensatory pathways and disease-relevant signatures.
How CRISPR Can Be Used to Study GO:0070676 intralumenal vesicle formation
Knockout
CRISPR knockout of genes such as VPS4, BRO1, or ESCRT subunits is used to determine their essentiality in intralumenal vesicle formation. Knockout cells typically exhibit reduced ILV numbers, impaired receptor degradation, and altered exosome secretion. These models are valuable for dissecting the core machinery and identifying compensatory pathways.
Point Mutation
Point mutations can be introduced into catalytic residues or interaction domains of ESCRT components to study their specific functions. For example, mutating the ATPase domain of Vps4 or the Bro1-binding interface can reveal how these proteins regulate ILV formation without affecting other cellular processes. Point mutations also model disease-associated variants, such as those in CHMP4B linked to neurodegeneration.
Knock-in
Knock-in of tagged or mutant alleles allows for precise tracking and functional analysis of ESCRT proteins. Fluorescent tags (e.g., GFP, mCherry) knocked into endogenous loci enable live-cell imaging of ILV formation under physiological expression levels. Disease-relevant mutations can also be knocked in to study their impact on ILV formation and cellular phenotypes.
Overexpression
Overexpression of ESCRT components or regulatory proteins such as Lgd or Bro1 can amplify ILV formation or disrupt stoichiometry, leading to altered MVB morphology. Overexpression studies have been instrumental in identifying the roles of Bro1 in stimulating Vps4 and Lgd in controlling ESCRT-III accumulation. These models are useful for gain-of-function analyses and for producing large quantities of ILVs for biochemical studies.
How EDITGENE Supports intralumenal vesicle formation Research
Researchers studying intralumenal vesicle formation-related genes often need to determine whether a candidate gene is causally involved in the process, how specific mutations affect ESCRT function, or whether modulating gene expression alters exosome cargo. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for intralumenal vesicle formation research.
Frequently Asked Questions About intralumenal vesicle formation
What is intralumenal vesicle formation?
Intralumenal vesicle formation is the process by which the endosomal membrane invaginates to form vesicles within the endosome lumen, defining the multivesicular body.
What genes are involved in intralumenal vesicle formation?
Key genes include VPS4, BRO1, LGD, ESCRT-0, ESCRT-I, ESCRT-II, ESCRT-III subunits, and accessory proteins like ALIX and TSG101.
What is the role of ESCRT in intralumenal vesicle formation?
The ESCRT machinery recognizes ubiquitinated cargo, induces membrane curvature, and catalyzes scission to form intralumenal vesicles.
How is intralumenal vesicle formation regulated?
It is regulated by sequential recruitment of ESCRT complexes, Bro1-mediated stimulation of Vps4, Lgd control of ESCRT-III accumulation, and lipid composition.
What diseases are associated with defective intralumenal vesicle formation?
Defects are linked to cancer, neurodegeneration, liver fibrosis, and peroxisomal disorders.
What methods are used to study intralumenal vesicle formation?
Common methods include electron microscopy, live-cell fluorescence imaging, proteomics, RNA sequencing, and CRISPR-based genetic screens.
Can CRISPR be used to study intralumenal vesicle formation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this process.
What is the difference between intralumenal vesicle formation and exosome biogenesis?
Intralumenal vesicle formation is the inward budding of the endosomal membrane to form ILVs; exosome biogenesis involves the release of these ILVs as exosomes upon MVB fusion with the plasma membrane.
What is the role of Bro1 in intralumenal vesicle formation?
Bro1 stimulates the Vps4 ATPase to promote ESCRT-III disassembly and drive intralumenal vesicle formation.
How does Lgd regulate intralumenal vesicle formation?
Lgd regulates the accumulation of ESCRT-III at multivesicular endosomes to control intralumenal vesicle formation.
Conclusion
Intralumenal vesicle formation (GO:0070676) is a conserved and essential cellular process that governs protein degradation, exosome biogenesis, and intercellular communication. The ESCRT machinery, along with regulatory proteins such as Bro1 and Lgd, orchestrates the invagination and scission of the endosomal membrane to form intralumenal vesicles. Dysregulation of this process is implicated in cancer, neurodegeneration, and liver fibrosis, making it a compelling target for therapeutic intervention. Continued research using advanced CRISPR models, imaging, and omics approaches will further illuminate the molecular details and disease relevance of intralumenal vesicle formation.
References
- 1. Kalluri R. 2024. The biology and function of extracellular vesicles in immune response and immunity.. Immunity 57(8):1752-1768 PMID: 39142276
- 2. Scott CC et al.. 2014. Endosome maturation, transport and functions.. Semin Cell Dev Biol 31:2-10 PMID: 24709024
- 3. Tharp NE et al.. 2026. PEX11 mediates intralumenal vesicle formation in peroxisomes.. Nat Commun 17(1) PMID: 42014717
- 4. Otegui MS. 2018. ESCRT-mediated sorting and intralumenal vesicle concatenation in plants.. Biochem Soc Trans 46(3):537-545 PMID: 29666213
- 5. Tseng CC et al.. 2021. Bro1 stimulates Vps4 to promote intralumenal vesicle formation during multivesicular body biogenesis.. J Cell Biol 220(8) PMID: 34160559
- 6. Clarke AL et al.. 2022. Lgd regulates ESCRT-III complex accumulation at multivesicular endosomes to control intralumenal vesicle formation.. Mol Biol Cell 33(14):ar144 PMID: 36287829
- 7. Zhang XW et al.. 2020. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation.. Autophagy 16(5):782-796 PMID: 31286822
- 8. Sakai Y et al.. 2026. Microautophagy: definition, classification, and the complexity of the underlying mechanisms.. Autophagy 22(1):3-9 PMID: 40928057
